196 related articles for article (PubMed ID: 34763039)
1. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
Ji LN; Wu S; Fu DQ; Fang SJ; Xie GQ; Fan YS; Bao J
J Ethnopharmacol; 2022 Feb; 284():114815. PubMed ID: 34763039
[TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
3. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
Shui B; Xia W; Wen C; Ding X
J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
[TBL] [Abstract][Full Text] [Related]
4. Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages
Ji L; Fan X; Hou X; Fu D; Bao J; Zhuang A; Chen S; Fan Y; Li R
Front Pharmacol; 2020; 11():1049. PubMed ID: 32760274
[TBL] [Abstract][Full Text] [Related]
5. Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys.
Du L; Feng Y; Wang C; Shi X; Wen C; He Z; Zhang Y
J Ethnopharmacol; 2022 Nov; 298():115643. PubMed ID: 36031105
[TBL] [Abstract][Full Text] [Related]
6. Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.
Ji L; Hou X; Deng X; Fan X; Zhuang A; Zhang X; Li R
Evid Based Complement Alternat Med; 2019; 2019():2357217. PubMed ID: 31781262
[TBL] [Abstract][Full Text] [Related]
7. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4
Huang S; Peng J; Gan Y; Chen L; Zhu Z; Tian F; Ji L; Fan Y; Zhou C; Bao J
J Ethnopharmacol; 2023 Dec; 317():116776. PubMed ID: 37343653
[TBL] [Abstract][Full Text] [Related]
8. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
9. MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes.
Dou L; Wang S; Huang X; Sun X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Mol Med Rep; 2018 Mar; 17(3):3967-3971. PubMed ID: 29257352
[TBL] [Abstract][Full Text] [Related]
10. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis.
Chang JS; Jun HJ; Park M
Physiol Rep; 2016 Oct; 4(20):. PubMed ID: 27798359
[TBL] [Abstract][Full Text] [Related]
12. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
14. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
16. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
17. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
Liu J; Ma Q; Sun Q; Luo Q; Wang Y; Wang C; Zhu A; Zhao L; Yin L; Lou J; Dong Y; Qiu P
Oxid Med Cell Longev; 2022; 2022():4301033. PubMed ID: 35855861
[TBL] [Abstract][Full Text] [Related]
19. Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation.
He Y; Tian W; Zhang M; Qiu H; Li H; Shi X; Song S; Wen C; Chen J
J Ethnopharmacol; 2023 Jun; 309():116283. PubMed ID: 36898449
[TBL] [Abstract][Full Text] [Related]
20. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
Aatsinki SM; Buler M; Salomäki H; Koulu M; Pavek P; Hakkola J
Br J Pharmacol; 2014 May; 171(9):2351-63. PubMed ID: 24428821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
